Antony Koblish - Feb 23, 2023 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role: Chief Executive Officer
Signature: /s/ Megan Smeykal, Attorney-in-fact
Stock symbol: TELA
Transactions as of: Feb 23, 2023
Transactions value $: -$66,555
Form type: 4
Date filed: 2/27/2023, 06:16 PM
Previous filing: Apr 1, 2022
Next filing: Apr 4, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TELA	Common Stock	Award	$0	+61.2K	+25.73%	$0.00	299K	Feb 23, 2023	Direct	F1
transaction	TELA	Common Stock	Tax liability	-$66.6K	-6.03K	-2.02%	$11.03	293K	Feb 24, 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TELA	Stock Option (Right to Buy)	Award	$0	+96.1K		$0.00	96.1K	Feb 23, 2023	Common Stock	96.1K	$10.50	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates.
F2	Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
F3	The option vests 25% on February 23, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.